Rousselot® is the global leader in collagen-based solutions, pioneering the development and production of pharmaceutical grade gelatins designed for diagnostics and bioabsorbable clinical applications. Since the launch of its biomedical segment, Rousselot Biomedical has expanded its portfolio with pure (Quali-Pure®) and ultra-pure (X-Pure®) gelatins. The latest range includes customized, modified gelatins, produced under controlled conditions and compliant with the most rigorous quality controls. The production process ensures standardized, high quality, pure and consistent biomaterials, thereby accelerating the translation of research to clinical practice. Rousselot is the first company producing GMP-grade GelMA, which, due to its functional equivalence to the research grade product, minimizes the need for revalidation when transitioning into clinical development. Rousselot Biomedical is committed to supporting the use of X-Pure and Quali-Pure in your applications and to help “Advancing medical science”. Rousselot is Darling Ingredient’s Health brand.
This innovator is on:
Economic sectors this organisation is active in:
MANUFACTURING > Other manufacturing
PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES > Scientific research and development
X-Pure GelMA customizable gelatin
Download
Any video or documents linked to above have been placed on this page by ROUSSELOT and their presence on this page does not imply endorsement by the European Commission nor is the European Commission responsible for the content of these materials.
Partnership
This organisation is seeking partnerships of the following nature:
Research Partners
Strategic Business Partners
Innovations
This organisation has been identified as a Key Innovator for the following 2 EU-funded innovations:
All innovations listed above are ranked by freshness of data, i.e. the innovations most recently analysed by Innovation Radar appear at the top